Zoetis Inc.

ZTS · NYSE · SIC 2834: Pharmaceutical Preparations · Market Cap: $49.9B · 14,500 employees
112
SEC Filings
$117.86
Close 2026-04-10
1
Transcripts
14,500
Employees

Business Summary

Zoetis Inc. is a global animal health company focused on the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests, and precision animal health solutions. It serves eight core species across companion animals (dogs, cats, horses) and livestock (cattle, swine, poultry, fish, sheep). Key products include Apoquel, Cytopoint, Librela, Simparica, and Fostera. In 2025, the company reported total revenue of approximately $9.35 billion across U.S. and International segments.

Latest Stock Quote

ZTS 2026-04-10 $117.86 O:$120.38 H:$120.75 L:$117.22 Vol:2.4M VWAP:$117.973
origin leaf: f18dc239a4c542a5230adbfecb07c67060ddd0dde0a08ac0be1b8c6fc01261cd

Next Earnings

Q2 FY2026 — expected 2026-08-16

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionZTSdiscussed Artificial Intelligence
topic_mentionZTSdiscussed Blockchain & Crypto
topic_mentionZTSdiscussed Supply Chain
topic_mentionZTSdiscussed Regulation
topic_mentionZTSdiscussed Enterprise
metricZTS revenuereported $2.4 Billion
metricZTS revenuereported $9.5 Billion
metricZTS net incomereported $603 Million
metricZTS net incomereported $648 Million
metricZTS net incomereported $2.7 Billion
metricZTS net incomereported $2.8 Billion
metricZTS EPSreported $1.48
metricZTS EPSreported $6.41
metricZTS EPSreported $6.65
metricZTS marginreported $82.8
metricZTS marginreported $67.4
metricZTS marginreported $83.5
metricZTS marginreported $69.2
topic_mentionZTSdiscussed Artificial Intelligence
topic_mentionZTSdiscussed Quantum Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-122025-12-310001555280-26-000011EDGAR82K words
2025-02-132024-12-310001555280-25-000102EDGAR
2024-02-132023-12-310001555280-24-000143EDGAR
2023-02-142022-12-310001555280-23-000074EDGAR
2022-02-152021-12-310001555280-22-000078EDGAR
2021-02-162020-12-310001555280-21-000098EDGAR
2020-02-132019-12-310001555280-20-000054EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-042025-09-300001555280-25-000274EDGAR32K words
2025-08-052025-06-300001555280-25-000261EDGAR
2025-05-062025-03-310001555280-25-000203EDGAR
2024-11-042024-09-300001555280-24-000332EDGAR
2024-08-062024-06-300001555280-24-000299EDGAR
2024-05-022024-03-310001555280-24-000249EDGAR
2023-11-022023-09-300001555280-23-000247EDGAR
2023-08-082023-06-300001555280-23-000205EDGAR
2023-05-042023-03-310001555280-23-000150EDGAR
2022-11-032022-09-300001555280-22-000276EDGAR
2022-08-042022-06-300001555280-22-000231EDGAR
2022-05-052022-03-310001555280-22-000174EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-120001555280-26-000008EDGAR13K words
2026-02-050001555280-26-000003EDGAR
2025-12-180001193125-25-324853EDGAR
2025-12-110001555280-25-000282EDGAR
2025-12-020001555280-25-000280EDGAR
2025-11-040001555280-25-000272EDGAR
2025-10-280001555280-25-000266EDGAR
2025-10-090001555280-25-000264EDGAR
2025-08-270001193125-25-189772EDGAR
2025-08-180001193125-25-182451EDGAR

112 total filings indexed. 83 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Earnings Transcripts

Call DateQuarterTitle
ZTS Earnings Call Transcript

Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

companion-animal-health-(dogs,-cats,-horses) livestock-health-(cattle,-swine,-poultry,-fish,-sheep) animal-health-diagnostics parasiticides vaccines dermatology anti-infectives pain-and-sedation biodevices-and-genetic-testing contract-manufacturing-services

Company Identity

CIK0001555280
TickerZTS
ExchangeNYSE
SIC2834: Pharmaceutical Preparations
HeadquartersParsippany, New Jersey
Websitehttps://www.zoetis.com
Listed2013-02-01

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: a2506d720a2e213ef47d5af5eceb215d5103b84f89740f2929c38e0a6bfea941
parent: 797144be7755689b876e80930bae47265e3e9709bbfe849ad75d37f42bfdaeb8
content hash: fb4a556ba9f3891c8c974ca002c2e35de0d54bd348130034fc61b013aed25b24
signed: 2026-04-13T04:48:23.951Z
sources: 21 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf